Open Access

Prevalence of classic, MLB-clade and VA-clade Astroviruses in Kenya and The Gambia

  • Caroline T. Meyer1,
  • Irma K. Bauer1,
  • Martin Antonio2,
  • Mitchell Adeyemi2,
  • Debasish Saha2, 3,
  • Joseph O. Oundo4,
  • John B. Ochieng4,
  • Richard Omore4,
  • O. Colin Stine5,
  • David Wang1 and
  • Lori R. Holtz1Email author
Virology Journal201512:78

https://doi.org/10.1186/s12985-015-0299-z

Received: 23 January 2015

Accepted: 15 April 2015

Published: 15 May 2015

Abstract

Background

Infectious diarrhea leads to significant mortality in children, with 40 % of these deaths occurring in Africa. Classic human astroviruses are a well-established etiology of diarrhea. In recent years, seven novel astroviruses have been discovered (MLB1, MLB2, MLB3, VA1/HMO-C, VA2/HMO-B, VA3/HMO-A, VA4); however, there have been few studies on their prevalence or potential association with diarrhea.

Methods

To investigate the prevalence and diversity of these classic and recently described astroviruses in a pediatric population, a case–control study was performed. Nine hundred and forty nine stools were previously collected from cases of moderate-to-severe diarrhea and matched controls of patients less than 5 years of age in Kenya and The Gambia. RT-PCR screening was performed using pan-astrovirus primers.

Results

Astroviruses were present in 9.9 % of all stool samples. MLB3 was the most common astrovirus with a prevalence of 2.6 %. Two subtypes of MLB3 were detected that varied based on location in Africa. In this case–control study, Astrovirus MLB1 was associated with diarrhea in Kenya, whereas Astrovirus MLB3 was associated with the control state in The Gambia. Classic human astrovirus was not associated with diarrhea in this study. Unexpectedly, astroviruses with high similarity to Canine Astrovirus and Avian Nephritis Virus 1 and 2 were also found in one case of diarrhea and two control stools respectively.

Conclusions

Astroviruses including novel MLB- and VA-clade members are commonly found in pediatric stools in Kenya and The Gambia. The most recently discovered astrovirus, MLB3, was the most prevalent and was found more commonly in control stools in The Gambia, while astrovirus MLB1 was associated with diarrhea in Kenya. Furthermore, a distinct subtype of MLB3 was noted, as well as 3 unanticipated avian or canine astroviruses in the human stool samples. As a result of a broadly reactive PCR screen for astroviruses, new insight was gained regarding the epidemiology of astroviruses in Africa, where a large proportion of diarrheal morbidity and mortality occur.

Keywords

AstrovirusMLBVADiarrheaGastroenteritis

Background

Diarrheal disease is a leading cause of death in children under five years of age worldwide [1], and a high proportion of these deaths, approximately 40 %, occur in Africa [2]; however this population has been rarely studied [3]. Additionally, infectious diarrhea causes significant morbidity including growth faltering, malnutrition and impaired cognitive development [4].

Classic human astroviruses (HAstV) are a well-established etiology of viral gastroenteritis, causing approximately 2 % to 8 % of childhood diarrhea in Africa [510]. All 8 serotypes of HAstV have been associated with diarrhea. Since 2008, seven highly divergent astroviruses (MLB1, MLB2, MLB3, VA1/HMO-C, VA2/HMO-B, VA3/HMO-A, VA4) have been discovered in human stool samples [1116]. To date, there have been few prevalence studies and no definitive disease association established for these viruses.

MLB1 was the first of these to be discovered and has been detected in stools across the world including Australia, Asia, Africa, North America and Europe [11, 13, 1522]. Furthermore a seroepidemiologic study of MLB1 demonstrated that primary exposure occurs in childhood and that seropositivity reached 100 % by adulthood [23]. One case–control study of MLB1 has been reported of Indian children that did not show an association of MLB1 with diarrhea [24]. MLB2 was initially discovered in stool, and MLB2 viremia in a febrile child has been described [25]. MLB3 was described recently in India in 2013 and found in 0.6 % of stools sampled [12].

VA1/HMO-C was first identified in an unexplained outbreak of gastroenteritis [14] and has since been detected in the brain of multiple immunocompromised patients with encephalitis [2628]. This virus has been found to have a seroprevalence of 65 % in adults [29]. VA2/HMO-A and VA3/HMO-B have been described in stools from Nigeria, Pakistan, and India, while VA2/HMO-A has additionally been found in stools from the United States, China and Egypt [11, 13, 18, 21]. VA4 was recently discovered in 2 stool samples from Nepal [12].

Due to the limited data on these novel astroviruses, the objective of this study was to explore the prevalence and diversity of astroviruses in a pediatric population using cases of moderate-severe diarrhea (MSD) and matched controls in Kenya and The Gambia.

Results

Astroviruses were present in 9.9 % of all samples and represented primarily a mixture of classic, MLB and VA astroviruses (MLB3 2.6 %, HAstV 2.5 %, MLB1 1.7 %) (Table 1). MLB3 was the most prevalent astrovirus, followed by HAstV and MLB1.
Table 1

Astrovirus Screening Results

 

Kenya

The Gambia

All samples

 
 

Cases

Controls

p

Cases

Controls

p

Cases

Controls

p

Total

n = 181

n = 181

 

n = 266

n = 321

 

n = 447

n = 502

 

n = 949

HAstV

7

4

0.3270

5

8

0.4609

12

12

0.9432

24

MLB1

11

1

0.0217*

2

2

1.000

13

3

0.0221*

16

MLB2

0

1

0.9907

2

7

0.2722

2

8

0.1808

10

MLB3

1

6

0.9864

3

15

0.0421*

4

21

0.0071*

25

VA1

0

0

N/A

0

1

0.9857

0

1

0.9857

1

VA2

2

2

1.0000

4

6

0.9435

6

8

0.9569

14

VA3

0

0

N/A

0

0

N/A

0

0

N/A

0

VA4

0

0

N/A

0

0

N/A

0

0

N/A

0

Total

21

14

N/A

16

39

N/A

37

53

N/A

90

HAstV- Human Astrovirus

N/A- Not applicable

*Significant at p < 0.05

Total does not include additional astroviruses including Canine Astrovirus, Avian Nephritis Virus 1 and 2, and VA5

MLB3 was detected more frequently in controls than in diarrhea cases in The Gambia (4.7 % controls vs 1.1 % cases; p = 0.0421) as well as overall (4.2 % controls vs 0.9 % cases; p = 0.0071). Sequencing of the amplicons from the MLB3 positive samples from 6 of 7 Kenyan samples yielded sequences that shared 97-99 % identity with the reference MLB3 strain. However, the seventh Kenyan sample and all 18 positive samples from The Gambia shared only 88–89 % identity to the reference MLB3 strain, demonstrating that a previously unrecognized diversity of MLB3 subtypes exists (Fig. 1).
Fig. 1

Phylogenetic Analysis of MLB3 amplicons. Amplicons measuring 409 nucleotides in length from ORF 1b were used for phylogenetic analysis. Significant bootstrap values (>700) are shown. Scale bar represents the number of nucleic acid differences. GenBank accession numbers or sample numbers are listed for reference

MLB1 was significantly associated with diarrhea in Kenya (6.1 % cases vs 0.6 % controls; p = 0.0217). All of the MLB1 positive stools in Kenya occurred in a 4 month timeframe of stool collection between May-August of 2008 with 7 of the 12 positive samples collected within 12 days. By contrast, prevalence of MLB1 was lower in The Gambia, 3 of the 4 detections occurred in March and April, and no association with diarrhea was observed (0.8 % cases vs. 0.6 % controls). There was no difference in the prevalence of classic astroviruses between cases and controls (2.7 % cases vs. 2.4 % controls). VA-clade viruses were detected at low prevalence (VA1 and VA2) or not at all (VA3 and VA4).

The results of previous microbiologic testing for 17 diarrhea pathogens for these samples [3] were used to determine if any of the known pathogens were detected with any astrovirus more frequently than by chance. Prevalence of Campylobacter jejuni infections in the aggregate Kenya and The Gambia population was 4.5 % (5.8 % of cases and 3.4 % of controls) (Table 2). Co-detection of MLB1 and Campylobacter jejuni was significant; 5 of the 16 stools positive for MLB1 were also positive for C. jejuni (p = 0.0005). All five of the samples with both MLB1 and C. jejuni were diarrhea cases.
Table 2

Campylobacter jejuni and MLB1 Co-detection

 

MLB1 Negative

MLB1 Positive

Total

Campylobacter Negative

895 (94.3 %)

11 (1.2 %)

906

Campylobacter Positive

38 (4.0 %)

5 (0.5 %)*

43

Total

933

16

949

*Co-detection of MLB1 and Campylobacter jejuni was significant at p = 0.0005 using Fisher exact test, 95 % CI (2.757–35.260)

Sequencing of the pan-astrovirus primer derived amplicons also yielded several unexpected results. A 415 nucleotide (nt) amplicon [GenBank: KJ777800] from a Kenyan case stool shared 95 % nucleotide identity to Canine astrovirus strain 915 [GenBank: JX878480]. In addition, a 439 nt amplicon [GenBank: KJ777802] from a Kenyan control stool shared 92 % identity to Avian Nephritis Virus 2 [GenBank: HQ188698] [30], while a 439 nt amplicon [GenBank: KJ777801] from a Gambian control sample shared 94 % identity to Avian Nephritis Virus 1 [GenBank: AB033998] [31]. Finally, a 433 nt amplicon from a control sample from the Gambia shared only 77 % nucleotide identity to VA4. We sequenced the nearly-complete genome of 6519 nt [GenBank: KJ656124], which we tentatively named astrovirus VA5 (Fig. 2). Further analysis demonstrated that this sequence shared 94 % nucleotide identity to a very recently published sequence Human astrovirus BF34 [GenBank: KF859964] [32]. VA5 contains characteristic astrovirus motifs such as a heptameric slippery sequence (AAAAAAC) and a stem-loop II in the 3′ UTR.
Fig. 2

Phylogenetic Analysis of Astrovirus ORF2 capsid protein. The complete amino acid sequence from ORF2 was used for phylogenetic analysis. Significant bootstrap values (>700) are shown. Scale bar represents the number of amino acid differences. ANV: Avian Nephritis Virus

Discussion

In summary, astroviruses are commonly found in pediatric stool samples in Kenya and The Gambia. While there have been a few reports describing the prevalence of recently identified astroviruses in African countries such as Egypt and Nigeria [13, 18] there have been no studies from Kenya or The Gambia. Astrovirus MLB3 was recently discovered in India in 2013 [12] and has not been previously detected in Africa; however, it was the most frequently detected of all of the astroviruses in this study.

This is only the second study reporting MLB3 and the first case–control study of MLB3 performed. Compared to the initial study in India, MLB3 was detected at a prevalence four times higher in Africa [12]. Furthermore, there is a novel diversity of MLB3 viruses, as a distinct subtype of MLB3 that differed by > 10 % from the reference MLB3 was detected. Prior studies of the 8 classic human astrovirus serotypes have also shown geographic strain variation [33].

Interestingly, MLB3 was negatively associated with moderate-severe diarrhea in The Gambia. Although viruses are generally associated with undesirable consequences, a recent animal model showed that enteric viruses may also have beneficial functions [34]. In the animal model, murine norovirus provided protection against mucosal damage and supported intestinal homeostasis in germ-free and antibiotic-treated mice. The association of MLB3 with the control state, may indicate that MLB3 can similarly provide protection from diarrhea in this population. Alternatively, MLB3 may be a pathogen of another organ system and affected by diarrhea-associated changes in the gut.

There was a positive association between MLB1 and diarrhea in this matched case–control study in Kenya, raising the possibility that MLB1 may play a role in the etiology of diarrhea. However, no association was observed in The Gambia. In Kenya, there was a clustering of positive stools over a 12 day time period. This could indicate an outbreak of MLB1 leading to diarrhea and increased prevalence that was not captured in The Gambia. The association of MLB1 with diarrhea also differed from a prior case–control study in India [24]. Although the aggregate analysis of Kenya and The Gambia together still yields a statistically significant association with diarrhea overall (p = 0.0221), the different results from the two sites renders it difficult to make definitive conclusions.

Clearly the two geographic sites yielded distinct prevalence rates for both MLB1 and MLB3. Geographic variation of eukaryotic viruses occurs [35] and likely contributed to our findings. These observations underscore the need for additional studies in diverse geographic sites to better define the prevalence of these novel astroviruses.

This study showed a significant association between MLB1 and C. jejuni. Campylobacter is typically a food-borne or zoonotic disease [36], while classic human astrovirus is most commonly transmitted by human to human contact [33]. Although the route of transmission of MLB1 is currently unknown, the high rate of co-detection could be due to similar transmission of MLB1 and Campylobacter through food or water. Previous studies have shown that mixed infections with Campylobacter and other pathogens are common [37, 38], and specific virus-induced cell alterations enhanced the invasiveness of C. jejuni in a cell culture model [39]. These observations raise the question of whether there may be synergistic effects between these agents and whether those effects play a role in the etiology of diarrhea, as all co-detections occurred in cases with diarrhea.

Although HAstV is a well-established cause of diarrhea, it was not associated with moderate-severe diarrhea in this study. This observation may be due to the exclusion of mild cases of diarrhea typically associated with HAstV infection. This result also reflects some of the challenges of using the case–control approach for disease attribution as other well-defined human diarrhea pathogens have also failed in single case–control studies [40, 41].

Unexpectedly, there were sequences in human stool with high identity to Avian Nephritis Virus 1 and 2 and Canine Astrovirus. These observations may be the result of ingestion of infected meat, as this phenomenon has been described for plant viruses [17, 42] or may be related to environmental exposure to animals. Zoonotic infection has been postulated to occur in astroviruses due to the frequent occurrence of recombination events and wide range of species infected [43] and is another possibility. In addition, a novel astrovirus VA5, similar to the recently reported HAstV-BF34 was identified [32]. It was only the use of broadly reactive PCR primers in this study that enabled the detection of these unexpected or novel agents. Prior studies of the prevalence of classic HAstV used primers that targeted specifically Human Astroviruses 1–8. Those primers could not detect viruses such as Avian Nephritis Virus or Canine Astrovirus. With the dramatic increase the number of astrovirus species discovered, further optimization of consensus astrovirus primers and their application to analyze human cohorts may uncover much more about the types and frequency of astroviruses found in human stool.

Conclusions

In conclusion, astroviruses including the novel MLB- and VA-clades are commonly found in pediatric stools in Kenya and The Gambia and a wide range of astroviruses was detected in this population. One of the most recently discovered astroviruses, MLB3 was also the most prevalent. MLB1 was associated with diarrhea in Kenya, while MLB3 was found more commonly in the control stools in The Gambia. There is diversity within the species of MLB3. Unexpected animal astrovirus species were detected in human stool through the use of broadly reactive PCR primers. Additional studies are needed to better understand the role of these novel astroviruses in human health and disease.

Methods

Samples

This investigation utilized 949 stool samples from cases of moderate-severe diarrhea and matched controls aged 0–59 months participating in the Global Enteric Multicenter Study (GEMS) at two rural sites in Kenya and The Gambia [3]. Samples were collected from Kenya between April 2008 and December 2008 and from The Gambia between March 2008 and April 2009. The study was approved by ethics committees at the University of Maryland, Baltimore, MD, USA, and at both field sites.

Cases of moderate-severe diarrhea were defined as acute (onset within 7 days) with ≥ 3 loose stools within 24 hours and 1 of the following criteria: sunken eyes, loss of skin turgor, intravenous hydration prescribed, dysentery, or admission to hospital. For every enrolled case, one to three matched control children was enrolled. Controls were matched to every case by age (±2 months for patients aged 0–23 months and ±4 months for patients aged 24–59 months), sex and residence (same or nearby village as the patient with diarrhea) (Table 3). Controls were enrolled within 14 days of the index case and were excluded if they had diarrhea in the prior 7 days. All stools were previously screened for an array of bacterial, parasitic, and viral pathogens [44].
Table 3

Patient Demographics

 

Kenya

The Gambia

All samples

 
 

Cases

Controls

p

Cases

Controls

p

Cases

Controls

p

Total

n = 181

n = 181

 

n = 266

n = 321

 

n = 447

n = 502

 

n = 949

Age (mos)

17.4

17.5

0.985

16.4

18.0

0.0626

16.8

17.8

0.212

17.1

Gender (M)

55.8 %

55.8 %

1.000

56.4 %

55.5 %

0.820

56.2 %

55.6 %

0.859

55.8 %

In total, 362 stools from Kenya (181 cases, 181 controls) and 587 stools from The Gambia (266 cases, 321 controls) were available for analysis. A Welch two sample t-test was used to examine for differences in age between cases and controls. To assess for differences in gender between cases and controls a chi square test was performed. To determine if presence of specific astroviruses was associated with diarrhea a conditional logistic regression was performed. To analyze if there were significant co-infections with astroviruses and other known pathogens Fisher exact test was used. P values <0.05 were determined to be significant. All statistical analyses were done in SAS 9.3 (Carey, NC).

Screening

RT-PCR screening of nucleic acid extracted from stool filtrates was performed using a one-step kit (Qiagen) with pan-astrovirus primers SF0073 (5′-GATTGGACTCGATTTGATGG-3′) and SF0076 (5′-CTGGCTTAACCCACATTCC-3′) that target the RNA-dependent RNA polymerase as previously described [11]. Positive samples were then screened using primers designed to target the capsid region of classic human astroviruses [Mon269 (5′-CAACTCAGGAAACAGGGTGT-3′) and Mon270 (5′-TCAGATGCATTGTCATTGGT-3′)] and MLB1 [SF0053 (5′-CTGTAGCTCGTGTTAGTCTTAACA-3′) and SF0061(5′-GTTCATTGGCACCATCAGAAC-3′)] [11]. Pan-astrovirus derived amplicons from samples negative in both secondary screens were cloned into pCR4-TOPO vector (Invitrogen) and Sanger sequenced. Sequences were compared to the GenBank nr/nt database on May 7, 2014 and deposited [Genbank: KJ807476 to KJ807529, KJ777800 to KJ777802].

Full genome sequencing

Deep-sequencing was performed on the stool sample containing the newly described virus VA5 using the Roche Titanium FLX platform [14]. 1004 viral reads were identified using Virushunter [45] and assembled using Newbler generating a contig of 6519 nucleotides. The contig was confirmed by RT-PCR and 3′ rapid amplification of cDNA ends. The complete 5′ UTR was not successfully sequenced after multiple attempts. This 6519 base pair sequence was deposited in Genbank [Genbank: KJ656124].

Phylogenetic analysis

MLB3 nucleic acid amplicon sequences were aligned and maximum-likelihood trees were created by CLUSTALX version 2.1 with 1000 bootstrap replicates. Phylogenetic analysis of the recently described VA5 was performed by aligning amino acid sequences from the complete ORF2 with MUSCLE. Best-fit model was determined using Prottest (version 2.4) [46], and maximum-likelihood trees were generated using Phyml (version 3.0) [47].

Accession numbers for astrovirus sequences used in Fig. 2 are as follows: Turkey Astrovirus 1: CAB95007; Turkey Astrovirus 2: NP987088; Turkey Astrovirus 3: AAV37187; Duck Astrovirus: ACN82429; Guinea Fowl Astrovirus: JN985815; Chicken Astrovirus 1: NP620618; Chicken Astrovirus 2: BAB21617; Avian Nephritis Virus 1: HM029238; Avian Nephritis Virus 2: AEB15604; Pigeon Astrovirus: CBY02488; Rabbit Astrovirus: AEV92822; Astrovirus MLB1: YP002290968; Astrovirus MLB2: YP004934010; Astrovirus MLB3: JX857870; Canine Astrovirus: AEX00102; Dog Astrovirus: ADL27736; DogBari Astrovirus: HM045005; Sealion Astrovirus 1: ACR54272; Sealion Astrovirus 2: ACR54274; Sealion Astrovirus 4: JN420351; Sealion Astrovirus 5: JN420352; Sealion Astrovirus 6: JN420353; Sealion Astrovirus 9: JN420356; Porcine Astrovirus: BAA90309; Porcine Astrovirus 2: AER30006; Porcine Astrovirus 3: NC019494; Porcine Astrovirus 4: JF713713; Porcine Astrovirus 5: JF713711; Swine Astrovirus: ADV16836; Feline Astrovirus 1: AAC13556; Feline Astrovirus 2: NC022249; Human Astrovirus 1: NP059444; Human Astrovirus 2: L13745; Human Astrovirus 3: AAD17224; Human Astrovirus 4: AAY84779; Human Astrovirus 5: AAY46274; Human Astrovirus 6: CAA86616; Human Astrovirus 7: AAK31913; Human Astrovirus 8: AAF85964; Dolphin Astrovirus 1: ACR54280; Dolphin Astrovirus 3: HQ668129; Whale Astrovirus 2: HQ668143; Bat Astrovirus AFCD337: ACF75865; Bat Astrovirus LC03: ACN88720; Bat Astrovirus LD38: ACN88708; Bat Astrovirus LD71: ACN88712; Ovine Astrovirus: CAB95004; Astrovirus VA1: NC013060; Astrovirus VA2: GQ502193; Astrovirus VA3: JX857868; Astrovirus VA4: JX857869; Astrovirus VA5: KJ656124; Fox Astrovirus: KC692365; Mink Astrovirus: NP795336; Bovine Astrovirus B76: AED89609; Deer Astrovirus 1: HM447045; Deer Astrovirus 2: HM447046; Wild boar Astrovirus: AEZ67026; Murine Astrovirus: NC018702; Rat Astrovirus: HM450382.

Abbreviation

HAstV: 

Human Astrovirus

Declarations

Acknowledgements

This study was supported in part by the National Institutes of Health Pediatric Gastroenterology Research Training Program (5T32DK077653) from the NIDDK, National Institutes of Health/National Center for Research Resources Washington University-ICTS (KL2 RR024994), NIH grant U54 AI057160 to the Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Disease Research, Children’s Discovery Institute (MD-FR-2013-292), and the Bill & Melinda Gates Foundation (OPP1016839). D.W. holds an Investigators in the Pathogenesis of Infectious Disease award from the Burroughs Welcome Fund.

Authors’ Affiliations

(1)
Washington University School of Medicine
(2)
Medical Research Council Unit
(3)
Center for International Health, Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago
(4)
Kenya Medical Research Institute/Centers for Disease Control and Prevention
(5)
University of Maryland School of Medicine

References

  1. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379:2151–61.PubMedView ArticleGoogle Scholar
  2. Boschi-Pinto C, Velebit L, Shibuya K. Estimating child mortality due to diarrhoea in developing countries. Bull World Health Organ. 2008;86:710–7.PubMed CentralPubMedView ArticleGoogle Scholar
  3. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case–control study. Lancet. 2013;382:209–22.PubMedView ArticleGoogle Scholar
  4. Petri Jr WA, Miller M, Binder HJ, Levine MM, Dillingham R, Guerrant RL. Enteric infections, diarrhea, and their impact on function and development. J Clin Invest. 2008;118:1277–90.PubMed CentralPubMedView ArticleGoogle Scholar
  5. Platts-Mills JA, Gratz J, Mduma E, Svensen E, Amour C, Liu J, et al. Association between stool enteropathogen quantity and disease in Tanzanian children using TaqMan array cards: a nested case–control study. Am J Trop Med Hyg. 2014;90:133–8.PubMed CentralPubMedView ArticleGoogle Scholar
  6. Kiulia NM, Mwenda JM, Nyachieo A, Nyaundi JK, Steele AD, Taylor MB. Astrovirus infection in young Kenyan children with diarrhoea. J Trop Pediatr. 2007;53:206–9.PubMedView ArticleGoogle Scholar
  7. Cunliffe NA, Dove W, Gondwe JS, Thindwa BD, Greensill J, Holmes JL, et al. Detection and characterisation of human astroviruses in children with acute gastroenteritis in Blantyre, Malawi. J Med Virol. 2002;67:563–6.PubMedView ArticleGoogle Scholar
  8. Pennap G, Pager CT, Peenze I, de Beer MC, Kwaga JK, Ogalla WN, et al. Epidemiology of astrovirus infection in Zaria, Nigeria. J Trop Pediatr. 2002;48:98–101.PubMedView ArticleGoogle Scholar
  9. Basu G, Rossouw J, Sebunya TK, Gashe BA, de Beer M, Dewar JB, et al. Prevalence of rotavirus, adenovirus and astrovirus infection in young children with gastroenteritis in Gaborone, Botswana. East Afr Med J. 2003;80:652–5.PubMedGoogle Scholar
  10. Marx FE, Taylor MB, Grabow WOK. The prevalence of human astrovirus and enteric adenovirus infection in South African patients with gastroenteritis. South Afr J Epidemiol Infect. 1998;13:5–9.Google Scholar
  11. Finkbeiner SR, Holtz LR, Jiang Y, Rajendran P, Franz CJ, Zhao G, et al. Human stool contains a previously unrecognized diversity of novel astroviruses. Virol J. 2009;6:161.PubMed CentralPubMedView ArticleGoogle Scholar
  12. Jiang H, Holtz LR, Bauer I, Franz CJ, Zhao G, Bodhidatta L, et al. Comparison of novel MLB-clade, VA-clade and classic human astroviruses highlights constrained evolution of the classic human astrovirus nonstructural genes. Virology. 2013;436:8–14.PubMed CentralPubMedView ArticleGoogle Scholar
  13. Kapoor A, Li L, Victoria J, Oderinde B, Mason C, Pandey P, et al. Multiple novel astrovirus species in human stool. J Gen Virol. 2009;90:2965–72.PubMed CentralPubMedView ArticleGoogle Scholar
  14. Finkbeiner SR, Li Y, Ruone S, Conrardy C, Gregoricus N, Toney D, et al. Identification of a novel astrovirus (astrovirus VA1) associated with an outbreak of acute gastroenteritis. J Virol. 2009;83:10836–9.PubMed CentralPubMedView ArticleGoogle Scholar
  15. Finkbeiner SR, Le BM, Holtz LR, Storch GA, Wang D. Detection of newly described astrovirus MLB1 in stool samples from children. Emerg Infect Dis. 2009;15:441–4.PubMed CentralPubMedView ArticleGoogle Scholar
  16. Finkbeiner SR, Kirkwood CD, Wang D. Complete genome sequence of a highly divergent astrovirus isolated from a child with acute diarrhea. Virol J. 2008;5:117.PubMed CentralPubMedView ArticleGoogle Scholar
  17. Finkbeiner SR, Allred AF, Tarr PI, Klein EJ, Kirkwood CD, Wang D. Metagenomic analysis of human diarrhea: viral detection and discovery. PLoS Pathog. 2008;4:e1000011.PubMed CentralPubMedView ArticleGoogle Scholar
  18. Ahmed SF, Sebeny PJ, Klena JD, Pimentel G, Mansour A, Naguib AM, et al. Novel astroviruses in children, Egypt. Emerg Infect Dis. 2011;17:2391–3.PubMed CentralPubMedView ArticleGoogle Scholar
  19. Banyai K, Meleg E, Moschidou P, Martella V. Detection of newly described astrovirus MLB1 in stool samples from children. Emerg Infect Dis. 2010;16:169. author reply 169–170.PubMed CentralPubMedView ArticleGoogle Scholar
  20. Medici MC, Tummolo F, Calderaro A, Elia G, Banyai K, De Conto F, et al. MLB1 astrovirus in children with gastroenteritis, Italy. Emerg Infect Dis. 2014;20:169–70.PubMed CentralPubMedView ArticleGoogle Scholar
  21. Wang Y, Li Y, Jin Y, Li DD, Li X, Duan ZJ. Recently identified novel human astroviruses in children with diarrhea, China. Emerg Infect Dis. 2013;19:1333–5.PubMed CentralPubMedGoogle Scholar
  22. Matsumoto T, Wangchuk S, Tshering K, Yahiro T, Zangmo S, Dorji T, et al. Complete Genome Sequences of Two Astrovirus MLB1 Strains from Bhutanese Children with Diarrhea. Genome Announc. 2013;1.Google Scholar
  23. Holtz LR, Bauer IK, Jiang H, Belshe R, Freiden P, Schultz-Cherry SL, et al. Seroepidemiology of astrovirus MLB1. Clin Vaccine Immunol. 2014;21:908–11.PubMed CentralPubMedView ArticleGoogle Scholar
  24. Holtz LR, Bauer IK, Rajendran P, Kang G, Wang D. Astrovirus MLB1 is not associated with diarrhea in a cohort of Indian children. PLoS One. 2011;6(12):e28647.PubMed CentralPubMedView ArticleGoogle Scholar
  25. Holtz LR, Wylie KM, Sodergren E, Jiang Y, Franz CJ, Weinstock GM, et al. Astrovirus MLB2 viremia in febrile child. Emerg Infect Dis. 2011;17:2050–2.PubMed CentralPubMedView ArticleGoogle Scholar
  26. Quan PL, Wagner TA, Briese T, Torgerson TR, Hornig M, Tashmukhamedova A, et al. Astrovirus encephalitis in boy with X-linked agammaglobulinemia. Emerg Infect Dis. 2010;16:918–25.PubMed CentralPubMedView ArticleGoogle Scholar
  27. Naccache SN, Peggs KS, Mattes FM, Phadke R, Garson JA, Grant P, et al. Diagnosis of neuroinvasive astrovirus infection in an immunocompromised adult with encephalitis by unbiased next-generation sequencing. Clin Infect Dis. 2015;60:919–23.PubMed CentralPubMedView ArticleGoogle Scholar
  28. Brown JR, Morfopoulou S, Hubb J, Emmett WA, Ip W, Shah D, et al. Astrovirus VA1/HMO-C: An Increasingly Recognized Neurotropic Pathogen in Immunocompromised Patients. Clin Infect Dis. 2015;60:881–8.PubMed CentralPubMedView ArticleGoogle Scholar
  29. Burbelo PD, Ching KH, Esper F, Iadarola MJ, Delwart E, Lipkin WI, et al. Serological studies confirm the novel astrovirus HMOAstV-C as a highly prevalent human infectious agent. PLoS One. 2011;6:e22576.PubMed CentralPubMedView ArticleGoogle Scholar
  30. Pantin-Jackwood MJ, Strother KO, Mundt E, Zsak L, Day JM, Spackman E. Molecular characterization of avian astroviruses. Arch Virol. 2011;156:235–44.PubMedView ArticleGoogle Scholar
  31. Imada T, Yamaguchi S, Mase M, Tsukamoto K, Kubo M, Morooka A. Avian nephritis virus (ANV) as a new member of the family Astroviridae and construction of infectious ANV cDNA. J Virol. 2000;74:8487–93.PubMed CentralPubMedView ArticleGoogle Scholar
  32. Phan TG, Nordgren J, Ouermi D, Simpore J, Nitiema LW, Deng X, et al. New astrovirus in human feces from Burkina Faso. J Clin Virol. 2014;60:161–4.PubMed CentralPubMedView ArticleGoogle Scholar
  33. Bosch A, Pinto RM, Guix S. Human astroviruses. Clin Microbiol Rev. 2014;27:1048–74.PubMedView ArticleGoogle Scholar
  34. Kernbauer E, Ding Y, Cadwell K. An enteric virus can replace the beneficial function of commensal bacteria. Nature. 2014;516:94–8.PubMed CentralPubMedGoogle Scholar
  35. Holtz LR, Cao S, Zhao G, Bauer IK, Denno DM, Klein EJ, et al. Geographic variation in the eukaryotic virome of human diarrhea. Virology. 2014;468–470:556–64.PubMedView ArticleGoogle Scholar
  36. Allos BM. Campylobacter jejuni Infections: update on emerging issues and trends. Clin Infect Dis. 2001;32:1201–6.PubMedView ArticleGoogle Scholar
  37. Mason J, Iturriza-Gomara M, O'Brien SJ, Ngwira BM, Dove W, Maiden MC, et al. Campylobacter infection in children in Malawi is common and is frequently associated with enteric virus co-infections. PLoS One. 2013;8:e59663.PubMed CentralPubMedView ArticleGoogle Scholar
  38. Glass RI, Stoll BJ, Huq MI, Struelens MJ, Blaser M, Kibriya AK. Epidemiologic and clinical features of endemic Campylobacter jejuni infection in Bangladesh. J Infect Dis. 1983;148:292–6.PubMedView ArticleGoogle Scholar
  39. Konkel ME, Joens LA. Effect of enteroviruses on adherence to and invasion of HEp-2 cells by Campylobacter isolates. Infect Immun. 1990;58:1101–5.PubMed CentralPubMedGoogle Scholar
  40. Bodhidatta L, McDaniel P, Sornsakrin S, Srijan A, Serichantalergs O, Mason CJ. Case–control study of diarrheal disease etiology in a remote rural area in Western Thailand. Am J Trop Med Hyg. 2010;83:1106–9.PubMed CentralPubMedView ArticleGoogle Scholar
  41. Hien BT, Trang do T, Scheutz F, Cam PD, Molbak K, Dalsgaard A. Diarrhoeagenic Escherichia coli and other causes of childhood diarrhoea: a case–control study in children living in a wastewater-use area in Hanoi, Vietnam. J Med Microbiol. 2007;56:1086–96.PubMedView ArticleGoogle Scholar
  42. Zhang T, Breitbart M, Lee WH, Run JQ, Wei CL, Soh SW, et al. RNA viral community in human feces: prevalence of plant pathogenic viruses. PLoS Biol. 2006;4:e3.PubMed CentralPubMedView ArticleGoogle Scholar
  43. De Benedictis P, Schultz-Cherry S, Burnham A, Cattoli G. Astrovirus infections in humans and animals - molecular biology, genetic diversity, and interspecies transmissions. Infect Genet Evol. 2011;11:1529–44.PubMedView ArticleGoogle Scholar
  44. Panchalingam S, Antonio M, Hossain A, Mandomando I, Ochieng B, Oundo J, et al. Diagnostic microbiologic methods in the GEMS-1 case/control study. Clin Infect Dis. 2012;55 Suppl 4:S294–302.PubMed CentralPubMedView ArticleGoogle Scholar
  45. Zhao G, Krishnamurthy S, Cai Z, Popov VL, Da Rosa AP T, Guzman H, et al. Identification of novel viruses using VirusHunter–an automated data analysis pipeline. PLoS One. 2013;8:e78470.PubMed CentralPubMedView ArticleGoogle Scholar
  46. Abascal F, Zardoya R, Posada D. ProtTest: selection of best-fit models of protein evolution. Bioinformatics. 2005;21:2104–5.PubMedView ArticleGoogle Scholar
  47. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, Gascuel O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol. 2010;59:307–21.PubMedView ArticleGoogle Scholar

Copyright

© Meyer et al. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement